IL2 and neoplasm: In this context, it has been shown that Denileukin Difititox (DD), which is composed of IL-2 fused to the diphtheria toxin, can enhance anti-tumor immunity by interacting with the IL-2Rαβγ trimeric form selectively expressed on Treg cells, leading to their depletion [91,92].